Delay in diagnosis and treatment of squamous cell carcinoma of the skin.

Advanced squamous cell carcinomas (SCC) of the skin can cause significant tissue destruction and may metastasize. Understanding the determinants of patient delay could help prevent advanced presentation. The purpose of the present study was to examine patient- and healthcare-related factors associated with delay before the detection and treatment of SCC. A sample of 308 patients with SCC treated at a dermatological referral centre in Italy were interviewed. Clinical data were obtained from the medical records. The highest quartile patients reported > 9 months delay between noticing the lesion and the first medical visit (defined as long patient delay). Multivariate analysis showed that SCC arising on pre-existing chronic lesions were associated with long patient delay (odds ratio = 3.17; 95% confidence interval 1.1-9.3). Controlling for confounders, the first physician's advice to remove the lesion immediately was associated with a shorter treatment delay (p < 0.001). In conclusion, our work emphasizes the importance of seeing a doctor about any change in a pre-existing lesion, particularly in light of the fact that SCC on chronic lesions are at greater risk of metastasis and recurrence.

[1]  P. Pasquini,et al.  Factors associated with large cutaneous squamous cell carcinomas. , 2010, Journal of the American Academy of Dermatology.

[2]  J. Mones,et al.  Squamous‐cell carcinoma in situ is a fiction! , 2009, Journal of cutaneous pathology.

[3]  B. Schönfisch,et al.  Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. , 2008, The Lancet. Oncology.

[4]  Miquel Porta,et al.  A Dictionary of Epidemiology , 2008 .

[5]  P. Pasquini,et al.  Skin Cancer Knowledge and Preventive Behaviors among Patients with a Recent History of Cutaneous Squamous Cell Carcinoma , 2008, Dermatology.

[6]  J. Bhawan Squamous cell carcinoma in situ in skin: what does it mean? , 2007, Journal of cutaneous pathology.

[7]  M. Weinstock,et al.  Reliability of the histopathologic diagnosis of keratinocyte carcinomas. , 2007, Journal of the American Academy of Dermatology.

[8]  S. Menzies,et al.  Time to Diagnosis of Melanoma: Same Trend in Different Continents , 2007, Journal of cutaneous medicine and surgery.

[9]  S. Swetter,et al.  Effect of health care delivery models on melanoma thickness and stage in a university-based referral center: an observational pilot study. , 2007, Archives of dermatology.

[10]  D. English,et al.  The relationship between melanoma thickness and time to diagnosis in a large population-based study. , 2006, Archives of dermatology.

[11]  Kathylynn Saboda,et al.  Risk Group, Skin Lesion History, and Sun Sensitivity Reliability in Squamous Cell Skin Cancer Progression , 2006, Cancer Epidemiology Biomarkers & Prevention.

[12]  M. Weinstock,et al.  Relationship of treatment delay with surgical defect size from keratinocyte carcinoma (basal cell carcinoma and squamous cell carcinoma of the skin). , 2005, The Journal of investigative dermatology.

[13]  D. Zelac,et al.  Squamous cell carcinoma of the skin. , 2004, Plastic and reconstructive surgery.

[14]  David J Margolis,et al.  Validity of patient self-reported history of skin cancer. , 2004, Archives of dermatology.

[15]  R. Santambrogio,et al.  Factors of delay in the diagnosis of melanoma. , 2003, European journal of dermatology : EJD.

[16]  Steven R Feldman,et al.  Skin cancer is among the most costly of all cancers to treat for the Medicare population. , 2003, Journal of the American Academy of Dermatology.

[17]  P. G. Lang,et al.  Prognostic Factors for Metastasis in Squamous Cell Carcinoma of the Skin , 2002, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[18]  E. D. Smith,et al.  Cost of Nonmelanoma Skin Cancer Treatment in the United States , 2001, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[19]  D Ratner,et al.  Cutaneous squamous-cell carcinoma. , 2001, The New England journal of medicine.

[20]  B. Dréno,et al.  Delays in diagnosis and melanoma prognosis (II): The role of doctors , 2000, International journal of cancer.

[21]  J. Grob,et al.  Delays in diagnosis and melanoma prognosis (I): The role of patients , 2000, International journal of cancer.

[22]  A. Blum,et al.  Awareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatment , 1999, The British journal of dermatology.

[23]  A. Halpern,et al.  Patient knowledge, awareness, and delay in seeking medical attention for malignant melanoma. , 1999, Journal of clinical epidemiology.

[24]  W. Harmsen,et al.  Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992. , 1997, Archives of dermatology.

[25]  R. Carroll,et al.  Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. , 1992, Journal of the American Academy of Dermatology.

[26]  M. S. Blois,et al.  Patient and physician delay in melanoma diagnosis. , 1988, Journal of the American Academy of Dermatology.